Koers AL Capital Holdings 2016 Ltd TEL AVIV STOCK EXCHANGE
Aandelen
CPHO-M
IL0010843675
Farmaceutische producten
Omzet 2022 | 49,3 18,55K 45,94 | Omzet 2023 | 44,23 16,64K 41,22 | Marktkapitalisatie | 25,49 mln. 9,59 mld. 23,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -48 mln. -18,06 mld. -44,73 mln. | Nettowinst (verlies) 2023 | -88 mln. -33,12 mld. -82,01 mln. | EV/omzet 2022 | 1.234.605 x |
Nettoschuld 2022 | 17,5 mln. 6,59 mld. 16,31 mln. | Nettoschuld 2023 | 13,42 mln. 5,05 mld. 12,5 mln. | EV/omzet 2023 | 879.698 x |
K/w-verhouding 2022 |
-0,97
x | K/w-verhouding 2023 |
-0,22
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 66,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 70 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15-02-15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,72% | 2,85 mld. | |
+300,00% | 55,26 mln. |